Skip to content

Balanseat

Balanseat. RCT study on seated balance training with the Balanseat device in older people

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25419
Enrollment
88
Registered
2021-03-10
Start date
2021-03-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly with walking and balance problems.

Interventions

One group receives 20 minutes of exercise with the Balanseat, twice a week, over 6 weeks (total of 12 sessions), the control group their usual care.

Sponsors

Research group; Healthy Ageing, Allied Health Care and Nursing, Hanze University of Applied Sciences Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age 65+ years • Ability to walk at least 10 meters on a ?at surface, with or without an assistive device • Decreased walking speed; gait speed < 0.8 m/sec, during walk test • An informed consent was signed by the participant

Exclusion criteria

Exclusion criteria: • Individuals with a major disease or unstable health that prevents their participation • Individuals with amputees or who had surgery in the past three months • Individuals following physical therapy related to back, walking and/or balance problems • Individuals with MCI or dementia

Design outcomes

Primary

MeasureTime frame
- Therapy adherence; Adherence to the intervention will be assessed based on adherence to the balanseat program during the study. Adherence to the balanseat program will be calculated based on completion of exercise bouts. - Gait and balance parameters to be measured before, during (after 6 sessions) and after the intervention (post 12 sessions) include; timed up and go (TUG), 10 meter walk test (10MWT), short physical performance battery (SPPB), functional reach test (FRT) and Falls efficacy scale (FES).

Contacts

Public ContactHans Drenth

Hanze University of Applied Sciences

j.c.drenth@pl.hanze.nl(+31)50 - 595 3539

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)